Milestone Pharmaceuticals (MIST) Change in Acquisitions & Divestments (2018 - 2025)

Milestone Pharmaceuticals (MIST) posted Change in Acquisitions & Divestments of $34.5 million for Q1 2025, up 187.22% on a QoQ basis from $12.0 million in Q1 2021.

Milestone Pharmaceuticals (MIST) Change in Acquisitions & Divestments (2018 - 2025) Analysis & Trends

Milestone Pharmaceuticals' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $34.5 million for Q1 2025.

  • Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $34.5 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $92.5 million (changed N/A YoY) and the FY2025 annual result came in at $94.5 million, down 22.49% from the prior year.
  • Change in Acquisitions & Divestments was $34.5 million for Q1 2025 at Milestone Pharmaceuticals, up from $12.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $34.5 million in Q1 2025 and bottomed at $12.0 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Milestone Pharmaceuticals 148.53 Mn -35.69 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 34.47 Mn
Mar 31, 2025 34.47 Mn
Mar 31, 2021 12.00 Mn
Mar 31, 2021 12.00 Mn
Dec 31, 2020 16.00 Mn
Dec 31, 2020 16.00 Mn
Dec 31, 2019 30.00 Mn
Dec 31, 2019 30.00 Mn
Sep 30, 2019 5.00 Mn
Sep 30, 2019 5.00 Mn
Dec 31, 2018 3.01 Mn
Dec 31, 2018 3.01 Mn
Sep 30, 2018 983,000.00
Sep 30, 2018 983,000.00
Jun 30, 2018 8.03 Mn
Jun 30, 2018 8.03 Mn
Mar 31, 2018 7.00 Mn
Mar 31, 2018 7.00 Mn